Michael B. Jacobs, M.D.December 20, 2022

FDA 483 - Michael B. Jacobs, M.D. - December 20, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Michael B. Jacobs, M.D.

Record Details

Michael B. Jacobs, M.D. in Las Vegas, NV, was inspected for Bioresearch Monitoring and received a Form 483 with three observations. The inspection revealed significant issues including protocol deviations, failure to obtain proper informed consent for study procedures, and inadequate maintenance of case histories. These findings indicate a lack of adherence to regulatory requirements for clinical investigations.

Company: Michael B. Jacobs, M.D.
Inspection Date: December 20, 2022
Product Type: Drugs
Office: Division of Human and Animal Food Operations - West V
Person: Rebecca T. Davis (investigator)

Open in Dashboard

ID · c999d87b-8031-488c-b40b-c7a5013445d1